Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Locatelli

Showing results (71-80 of 376) with videos related to

Pageof 38
Sort By:
Expert Opinion on Pharmacotherapy|November 29, 2013
Optimal phosphate control: still an unmet need in chronic kidney disease patientsFrancesco Locatelli, Lucia Del Vecchio
Clinical Kidney Journal|September 9, 2020
Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19Lucia Del Vecchio, Francesco Locatelli
Current Opinion in Nephrology and Hypertension|May 31, 2018
Will there still be a role for the originator erythropoiesis-simulating agents after the biosimilars and the hypoxia-inducible factor stabilizers approval?Francesco Locatelli, Lucia Del Vecchio
Expert Opinion on Drug Safety|August 25, 2012
Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney diseaseLucia Del Vecchio, Francesco Locatelli
Expert Opinion on Pharmacotherapy|June 11, 2014
Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patientsFrancesco Locatelli, Nada Dimkovic, Goce Spasovski
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 12, 2010
[KDIGO guidelines for the diagnosis and treatment of chronic kidney disease mineral and bone disorder: what's new?]Monica Limardo, Giuseppe Pontoriero, Francesco Locatelli
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2013
Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trialFrancesco Locatelli, Nada Dimkovic, Goce Spasovski
The New England Journal of Medicine|May 10, 2013
Cinacalcet for cardiovascular disease in patients undergoing dialysisFrancesco Locatelli, Giuseppe Pontoriero, Flavia Tentori
Nature Reviews. Nephrology|November 26, 2009
The growing problem of intradialytic hypertensionFrancesco Locatelli, Andrea Cavalli, Benedetta Tucci
Blood Purification|July 4, 2015
A Randomized Trial on Health-Related Patient Satisfaction Level with High-Efficiency Online Hemodiafiltration versus High-Flux DialysisAyman Karkar, Mohammed Abdelrahman, Francesco Locatelli
Pageof 38

Showing results (71-80 of 376) with videos related to

Sort By:
Pageof 38
Expert Opinion on Pharmacotherapy|November 29, 2013
Optimal phosphate control: still an unmet need in chronic kidney disease patientsFrancesco Locatelli, Lucia Del Vecchio
Clinical Kidney Journal|September 9, 2020
Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19Lucia Del Vecchio, Francesco Locatelli
Current Opinion in Nephrology and Hypertension|May 31, 2018
Will there still be a role for the originator erythropoiesis-simulating agents after the biosimilars and the hypoxia-inducible factor stabilizers approval?Francesco Locatelli, Lucia Del Vecchio
Expert Opinion on Drug Safety|August 25, 2012
Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney diseaseLucia Del Vecchio, Francesco Locatelli
Expert Opinion on Pharmacotherapy|June 11, 2014
Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patientsFrancesco Locatelli, Nada Dimkovic, Goce Spasovski
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 12, 2010
[KDIGO guidelines for the diagnosis and treatment of chronic kidney disease mineral and bone disorder: what's new?]Monica Limardo, Giuseppe Pontoriero, Francesco Locatelli
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2013
Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trialFrancesco Locatelli, Nada Dimkovic, Goce Spasovski
The New England Journal of Medicine|May 10, 2013
Cinacalcet for cardiovascular disease in patients undergoing dialysisFrancesco Locatelli, Giuseppe Pontoriero, Flavia Tentori
Nature Reviews. Nephrology|November 26, 2009
The growing problem of intradialytic hypertensionFrancesco Locatelli, Andrea Cavalli, Benedetta Tucci
Blood Purification|July 4, 2015
A Randomized Trial on Health-Related Patient Satisfaction Level with High-Efficiency Online Hemodiafiltration versus High-Flux DialysisAyman Karkar, Mohammed Abdelrahman, Francesco Locatelli
Pageof 38